Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors for cancer treatment. Shows activity in modulating signaling pathways involved in tumor growth and cell proliferation. Investigated for potential use in targeted therapies against solid tumors and hematological malignancies. Also employed in research settings to study structure-activity relationships in quinoxaline-based compounds.